Mitsubishi Ufj Trust & Banking Corp Novo Cure LTD Transaction History

Mitsubishi Ufj Trust & Banking Corp

$43.4 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $389,988 - $542,906	-31,400 Reduced 22.17%	110,261 $1.72 Million
Q4 2023 Feb 09, 2024	SELL	$11.13 - $15.78 $113,859 - $161,429	-10,230 Reduced 6.74%	141,661 $2.11 Million
Q3 2023 Nov 09, 2023	SELL	$16.15 - $42.35 $958,631 - $2.51 Million	-59,358 Reduced 28.1%	151,891 $2.45 Million
Q2 2023 Aug 08, 2023	SELL	$40.29 - $82.51 $410,595 - $840,859	-10,191 Reduced 4.6%	211,249 $8.77 Million
Q1 2023 May 10, 2023	SELL	$56.44 - $118.81 $1.03 Million - $2.17 Million	-18,294 Reduced 7.63%	221,440 $13.3 Million
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $10.4 Million - $13.9 Million	-162,861 Reduced 40.45%	239,734 $17.6 Million
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $251,766 - $331,677	-3,703 Reduced 0.91%	402,595 $30.6 Million
Q2 2022 Aug 09, 2022	BUY	$56.6 - $89.9 $107,483 - $170,720	1,899 Added 0.47%	406,298 $28.2 Million
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $76,631 - $107,678	-1,274 Reduced 0.31%	404,399 $33.5 Million
Q4 2021 Feb 09, 2022	SELL	$75.08 - $121.99 $665,959 - $1.08 Million	-8,870 Reduced 2.14%	405,673 $30.5 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $993,718 - $1.66 Million	-8,554 Reduced 2.02%	414,543 $48.2 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $17.9 Million - $30.9 Million	-136,918 Reduced 24.45%	423,097 $93.9 Million
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $2.19 Million - $3.36 Million	-17,671 Reduced 3.06%	560,015 $74 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $4.9 Million - $7.6 Million	43,656 Added 8.17%	577,686 $100 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $1.07 Million - $2.06 Million	-18,470 Reduced 3.34%	534,030 $59.4 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $232,804 - $302,848	-4,070 Reduced 0.73%	552,500 $32.8 Million
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $3.91 Million - $6.56 Million	-68,469 Reduced 10.95%	556,570 $37.5 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $16.5 Million - $22.6 Million	-241,311 Reduced 27.85%	625,039 $52.7 Million
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $9.87 Million - $15.6 Million	-159,610 Reduced 15.56%	866,350 $64.8 Million
Q2 2019 Aug 07, 2019	SELL	$42.22 - $63.23 $2.16 Million - $3.24 Million	-51,220 Reduced 4.76%	1,025,960 $64.9 Million
Q1 2019 May 13, 2019	BUY	$31.96 - $56.12 $10.9 Million - $19.2 Million	342,161 Added 46.55%	1,077,180 $51.9 Million
Q4 2018 Feb 12, 2019	SELL	$28.72 - $52.63 $2.15 Million - $3.94 Million	-74,882 Reduced 9.25%	735,019 $24.6 Million
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $195,808 - $320,635	-6,119 Reduced 0.75%	809,901 $42.4 Million
Q2 2018 Aug 10, 2018	SELL	$19.85 - $32.0 $692,566 - $1.12 Million	-34,890 Reduced 4.1%	816,020 $25.5 Million
Q1 2018 May 11, 2018	BUY	$19.3 - $23.65 $16.4 Million - $20.1 Million	850,910 New	850,910 $18.6 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account